This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2015 Jul;173(1):302-4.

doi: 10.1111/bjd.13633. Epub 2015 May 18.

First-line combination therapy with rituximab and corticosteroids provides a high complete remission rate in moderate-to-severe bullous pemphigoid

Y T Cho¹, C Y Chu¹, L F Wang¹

Affiliations

PMID: 25529394
DOI: 10.1111/bjd.13633

First-line combination therapy with rituximab and corticosteroids provides a high complete remission rate in moderate-to-severe bullous pemphigoid

Y T Cho et al. Br J Dermatol. 2015 Jul.

. 2015 Jul;173(1):302-4.

doi: 10.1111/bjd.13633. Epub 2015 May 18.

Authors

Y T Cho¹, C Y Chu¹, L F Wang¹

Affiliation

¹ Department of Dermatology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, 10002, Taiwan.

PMID: 25529394
DOI: 10.1111/bjd.13633

No abstract available

PubMed Disclaimer

Similar articles

Coexistence of psoriasis and bullous pemphigoid: remission with low-dose methotrexate.
Gunay U, Gunduz K, Ermertcan AT, Kandiloğlu AR. Gunay U, et al. Cutan Ocul Toxicol. 2013 Jun;32(2):168-9. doi: 10.3109/15569527.2012.667030. Epub 2012 Mar 20. Cutan Ocul Toxicol. 2013. PMID: 22429144
Type XVII collagen ELISA indices significantly decreased after bullous pemphigoid remission.
Kusajima E, Akiyama M, Sato M, Natsuga K, Shimizu H. Kusajima E, et al. Int J Dermatol. 2011 Feb;50(2):238-40. doi: 10.1111/j.1365-4632.2010.04324.x. Int J Dermatol. 2011. PMID: 21244398 No abstract available.
[Bullous Pemphigoid Successfully Treated with Rituximab].
Silva N, Costa A, Salvador F, Serradeiro E. Silva N, et al. Acta Med Port. 2017 Mar 31;30(3):243-246. doi: 10.20344/amp.7812. Epub 2017 Mar 31. Acta Med Port. 2017. PMID: 28550834 Portuguese.
Evidence-based management of bullous pemphigoid.
Daniel BS, Borradori L, Hall RP 3rd, Murrell DF. Daniel BS, et al. Dermatol Clin. 2011 Oct;29(4):613-20. doi: 10.1016/j.det.2011.06.003. Epub 2011 Aug 6. Dermatol Clin. 2011. PMID: 21925006 Review.
Blistering rash in an older man.
Ward NJ, MacVane CZ. Ward NJ, et al. J Fam Pract. 2013 Mar;62(3):151-3. J Fam Pract. 2013. PMID: 23520587 Review.

See all similar articles

Cited by

Advancements in Bullous Pemphigoid Treatment: A Comprehensive Pipeline Update.
Karakioulaki M, Eyerich K, Patsatsi A. Karakioulaki M, et al. Am J Clin Dermatol. 2024 Mar;25(2):195-212. doi: 10.1007/s40257-023-00832-1. Epub 2023 Dec 29. Am J Clin Dermatol. 2024. PMID: 38157140 Free PMC article. Review.
Advancing Treatment in Bullous Pemphigoid: A Comprehensive Review of Novel Therapeutic Targets and Approaches.
Chen HC, Wang CW, Toh WH, Lee HE, Chung WH, Chen CB. Chen HC, et al. Clin Rev Allergy Immunol. 2023 Dec;65(3):331-353. doi: 10.1007/s12016-023-08973-1. Epub 2023 Oct 28. Clin Rev Allergy Immunol. 2023. PMID: 37897588 Review.
Targeting type 2 inflammation in bullous pemphigoid: current and emerging therapeutic approaches.
Toh WH, Lee HE, Chen CB. Toh WH, et al. Front Med (Lausanne). 2023 Aug 8;10:1196946. doi: 10.3389/fmed.2023.1196946. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37614956 Free PMC article. Review.
Biological treatment for bullous pemphigoid.
Oren-Shabtai M, Mimouni D, Nosrati A, Atzmony L, Kaplan B, Barzilai A, Baum S. Oren-Shabtai M, et al. Front Immunol. 2023 Apr 27;14:1157250. doi: 10.3389/fimmu.2023.1157250. eCollection 2023. Front Immunol. 2023. PMID: 37180101 Free PMC article.
Bullous pemphigoid: The role of type 2 inflammation in its pathogenesis and the prospect of targeted therapy.
Zhang L, Chen Z, Wang L, Luo X. Zhang L, et al. Front Immunol. 2023 Feb 16;14:1115083. doi: 10.3389/fimmu.2023.1115083. eCollection 2023. Front Immunol. 2023. PMID: 36875098 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- H1 Connect
Medical
- MedlinePlus Health Information